Beta Bionics closes upsized IPO of 13.8M shares at $17.00, raises $229.1M

Beta Bionics, Inc.

IPO of 13,800,000 shares at $17.00/share, including full exercise of underwriters' option for 1,800,000 additional shares.
Gross proceeds to Beta Bionics from IPO total $212.1M; combined with concurrent private placement, aggregate proceeds $229.1M.
Private placement: 1,000,000 shares sold to existing investor at IPO price of $17.00/share.
Shares began trading on Nasdaq Global Market on January 30, 2025 under ticker BBNX.
Lead bookrunners: BofA Securities, Piper Sandler, and Leerink Partners; Stifel bookrunner; Lake Street co-manager.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Beta Bionics, Inc.: Filed an amended and restated certificate of incorporation in connection with the closing of the IPO, effective January 31, 2025 (effective 2025-01-31).

Change: charter amendment
Effective: 2025-01-31

Exact text from the filing

In connection with the closing of the initial public offering (“IPO”) of shares of common stock of the Company, on January 31, 2025, the Company filed an amended and restated certificate of incorporation (the “Restated Certificate”) with the Secretary of State of the State of Delaware.

View on SEC.gov

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Beta Bionics, Inc.: Adopted amended and restated bylaws in connection with the closing of the IPO, effective January 31, 2025 (effective 2025-01-31).

Change: bylaw amendment
Effective: 2025-01-31

Exact text from the filing

Effective as of January 31, 2025, the Company adopted the amended and restated bylaws (the “Restated Bylaws”) in connection with the closing of the IPO.

View on SEC.gov

Browse all governance changes →

Beta Bionics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-25-018471

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.